Parkinson's Disease Study

Protocol Title

An Open-Label, Phase 2 Study to Assess the Safety and Efficacy of 99mTc-NC100697 Injection in Detecting or Excluding Striatal Dopaminergic Deficits in Subjects With 1 or More Signs of a Parkinsonian Syndrome

Principal Investigator

Alan Waxman, MD

IRB Approval Number


Medical Specialty Area



Patients with tremor and suspected Parkinson's Disease

IRB Approval Expiration Date

5/31/07 (continuation has been submitted)

The study is ongoing, and patients are undergoing follow up, but enrollment to new subjects is closed.

Contact Information

An Imaging Nurse or Technologist will discuss participating with you, if you are interested. Once screened for eligibility, you will be provided any preparation instructions required for the study.

Jessica Lee (Study Coordinator)
Phone: (310) 423-7546
Send Us a Message